August 21 2023 - Regeneron expands Eylea's label with high-dose approval

Regeneron expands Eylea's label with high-dose approval
Merck's Keytruda will top pharma's sales rankings in 2028
Which US regions are on the rise for life sciences?
Gilead's magrolimab once again placed on partial clinical hold
*please scroll down for all the latest news*

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudt;